Tiziana Life Sciences Ltd (TLSA)
Last updated: 2026-10-21 16:19:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Tiziana Life Sciences Ltd (TLSA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.02, with a market capitalization of $128.53M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $2.10. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$128.53M | |
$1.03 | |
$16.79 | |
$0.41 | |
$1.01 | |
296.08K | |
772.44K | |
-- | |
$2.10 | |
$0.76 | |
-- | |
-- |
Tiziana Life Sciences Ltd (TLSA) Stock Price Today
Tiziana Life Sciences Ltd (TLSA) is currently trading at $1.02 as of 2026-10-21 16:17:00, up 0.50% ($0.00) from the previous close of $1.01
During today's regular trading session, TLSA has traded between $0.41 and $16.79, with a trading volume of 296.08K shares. The current price is near the lower end of today's range.
Tiziana Life Sciences Ltd (TLSA) 7-Day Stock Price Change
Over the past seven days, Tiziana Life Sciences Ltd (TLSA) moved from $1.09 to $1.02, representing a decline of 6.88% ($0.08).
The stock traded between $0.97 and $1.20 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 443.14 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
TLSA 52-Week Price Position
Position in Range: 18.9%
TLSA is currently trading at $1.02, placing it 18.9% of the way from its 52-week low of $0.76 to its 52-week high of $2.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Tiziana Life Sciences Ltd (TLSA)?
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
Tiziana Life Sciences Ltd Information
| Employees | 10 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Tiziana Life Sciences Ltd (TLSA) Stock on MEXC
Eligible investors can buy real shares of Tiziana Life Sciences Ltd (TLSA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Tiziana Life Sciences Ltd (TLSA) stock price today?
2.Is TLSA stock going up or down today?
3.What is TLSA pre-market price?
4.What is TLSA after-hours price?
5.Is TLSA stock trading now?
6.Where does TLSA sit relative to its 52-week high and low?
7.What sector is Tiziana Life Sciences Ltd in?
8.What is Tiziana Life Sciences Ltd's market capitalization and where is it listed?
9.How is TLSA valued in terms of P/E ratio and EPS?
10.Does Tiziana Life Sciences Ltd pay a dividend?
Explore More US Stocks
Search Stocks
TLSA Stock Calculator
Estimate the value between TLSA shares and USD.
TLSA Shares to USD
1.00 TLSA shares = 1.015 USD
Calculations are estimates based on the latest available price and are for reference only.


